Max International

Max International

Max International, with a valuation of $50 million, is raising funds on Issuance Express. The company uses its proven cellular enhancement technology to create clinically validated supplements. Max International is known for its glutathione supplements that defend the cells against pollution, toxins, free radicals, radiation, and heavy metals, battle oxidative stress, increase antioxidant defense, and increase energy. The company has four US patents, product approvals in 21 countries, and a global distribution network. Jonathan Flicker founded Max International in February 2023. The current crowdfunding campaign has a minimum target of $50,000 and a maximum target of $5 million. The campaign proceeds will be used for marketing, inventory, and general corporate purposes.

Expand

Investment Overview

Raised this Round: Raised: $27,716

Deal Terms

Total Commitments ($USD)

Platform
Issuance Express
Start Date
08/14/2024
Close Date
04/30/2025
Min. Goal
$50,000
Max. Goal
$5,000,000
Min. Investment

$250

Security Type

Equity - Preferred

Series

Series A

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$10.00

Pre-Money Valuation

$50,000,000

Company & Team

Company

Year Founded
2023
Industry
Healthcare & Pharmaceuticals
Tech Sector
HealthTech
Distribution Model
B2B/B2C
Margin
High
Capital Intensity
Low
Location
Salt Lake City, Utah
Business Type
High Growth
Company Website
Visit Website

Team

Employees
100
Prior Founder Exits?
No
Founder Name
Kevin McFarlane

Financials

as of Fiscal Year 2023
 Revenue -0.4% YoY
$14,603,138
 Monthly Burn
$753,887
 Runway
1.7 months
Gross Margin
61%

Summary Profit and Loss Statement

FY 2023 FY 2022

Revenue

$14,603,138

$25,464,199

COGS

$5,720,486

$6,394,965

Tax

$140,160

$-15,642

 

 

Net Income

$-9,046,641

$-6,336,176

Summary Balance Sheet

FY 2023 FY 2022

Cash

$1,250,868

$1,245,473

Accounts Receivable

$421,530

$480,000

Total Assets

$4,831,920

$7,865,721

Short-Term Debt

$16,636,594

$24,892,670

Long-Term Debt

$167,482

$561,413

Total Liabilities

$16,804,076

$25,454,083

Create a free account today to gain access to Kingscrowd analytics and financials.

Upgrade to gain access

Pay Monthly
Annually (2 months free)

Edge

$12.50 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings Kingscrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars

Company Funding & Growth

Funding history

Total Prior Capital Raised
$17,983,442
VC Backed?
No
Close Date Platform Valuation Total Raised Security Type Status Reg Type
04/30/2025 Issuance Express $50,000,000 $27,716 Equity - Preferred Active RegCF
Create a free account today to gain access to Kingscrowd analytics.
Founders: enhance your startup's credibility on Kingscrowd. Create an account to claim this raise page.
Add to portfolio
Max International on Issuance Express 2024
Platform: Issuance Express
Security Type: Equity - Preferred
Valuation: $50,000,000
Price per Share: $10.00

Follow company

Follow Max International on Issuance Express 2024

Buy Max International's Deal Report

Max International Deal Report

Get Kingscrowd's comprehensive report on Max International including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Max International is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Max International deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge